Esloric Tablet 100 mg is a medical drug used in the treatment of gout and certain types of kidney stones. It is used to reduce urate production and reduce levels of serum uric acid. Esloric Tablet 100 mg is also used to treat cancer-related hyperuricemia and tumor lysis syndrome. It is an inhibitor of the enzyme xanthine oxidase, which is responsible for converting hypoxanthine to xanthine and then to uric acid. By limiting the amount of uric acid produced, Esloric Tablet 100 mg helps to lower concentrations of uric acid in the blood.
Esloric Tablet 100 mg is primarily used for the prevention and treatment of gout and kidney stones. It is also used to reduce the risk of recurrent gout attacks and to treat tumor lysis syndrome, a metabolic complication associated with cancer chemotherapy. Esloric Tablet 100 mg can also be used to prevent uric acid accumulation in the body caused by certain medical conditions, such as certain forms of kidney and bone marrow diseases.
| Brand Name | Esloric |
|---|---|
| Type | Tablet |
| Weight | 100 mg |
| Generic | Allopurinol |
| Manufacturer | Square Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Esloric Tablet 100 mg works by blocking the enzyme xanthine oxidase. This enzyme is responsible for converting hypoxanthine to xanthine and then to uric acid. This process is inhibited by Esloric Tablet 100 mg, which reduces the amount of uric acid produced in the body. By decreasing the amount of uric acid produced, Esloric Tablet 100 mg helps to reduce poor blood flow, inflammation, swelling, and pain, which are common symptoms of gout and other forms of arthritis or joint infection.
The effects of Esloric Tablet 100 mg can be noticed within 1-2 weeks of starting the treatment. Many patients who take Esloric Tablet 100 mg notice a reduction in pain and discomfort within this time frame, as Esloric Tablet 100 mg is effective in reducing the amount of uric acid in the bloodstream.
Esloric Tablet 100 mg is rapidly and almost completely absorbed after oral administration, with plasma concentrations reaching peak levels 1-2 hours after ingestion. The peak plasma concentration is proportional to the dose taken. Esloric Tablet 100 mg is widely distributed throughout the body, with a volume of distribution estimated at 0.5 to 1 L/kg.
Esloric Tablet 100 mg is mainly eliminated through the renal route. It is metabolized in the liver by the cytochrome P450 enzyme system. Some of the metabolites are excreted through the bile. Approximately 80% of an oral dose is excreted in the urine as unchanged drug and metabolites.
Esloric Tablet 100 mg should be taken orally, usually once daily or as directed by your doctor. It can be taken with or without food. Esloric Tablet 100 mg tablets should not be crushed, broken, or chewed before swallowing.
The most common side effects of Esloric Tablet 100 mg include nausea, vomiting, stomach pain, diarrhea, itching, rash, headache, dizziness, drowsiness, and joint pain. Other less common side effects may include muscle pain, fever, blood in the urine, inflammation of the eyes and liver or renal function test abnormalities. If any of these side effects occur, you should contact your doctor as soon as possible.
Esloric Tablet 100 mg has been associated with rare cases of serious and potentially fatal liver damage, while other toxicities such as rashes, angioedema, and Stevens-Johnson syndrome have been reported.
You should not take Esloric Tablet 100 mg if you are allergic to it or any of its components, or if you have a history of liver or kidney disease. Esloric Tablet 100 mg should be used with caution in patients with severe gout, kidney impairment, or diabetes. It should also be avoided in pregnant women unless clearly needed and some caution should be taken in nursing mothers. Additionally, you should inform your doctor if you have any allergies, are taking any other medications, or have any existing medical conditions.
Esloric Tablet 100 mg may interact with certain medications, including cholestyramine, thiazide diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and sulfinpyrazone. These interactions can increase, decrease, or alter the effectiveness of Esloric Tablet 100 mg or other medications. It is important to discuss any medication you are taking with your doctor before starting Esloric Tablet 100 mg.
Esloric Tablet 100 mg can interact with certain diseases or medical conditions, increasing, decreasing, or altering its effects. These include gout, kidney impairment, diabetes, hypothyroidism, liver disease, anemia, and hypertension. It is important to discuss any medical condition you have with your doctor before starting Esloric Tablet 100 mg.
Esloric Tablet 100 mg can interact with certain drugs, including cholestyramine, thiazide diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and sulfinpyrazone. These interactions can increase, decrease, or alter the effectiveness of Esloric Tablet 100 mg or other medications. It is important to discuss any medication you are taking with your doctor before starting Esloric Tablet 100 mg.
Consumption of foods and beverages containing caffeine, alcohol, or sugar can affect the absorption of Esloric Tablet 100 mg. Additionally, certain foods may increase or decrease the effectiveness of Esloric Tablet 100 mg. It is important to discuss any dietary plan you have with your doctor before starting Esloric Tablet 100 mg.
Esloric Tablet 100 mg is classified as pregnancy category D due to its potential to cause harm to the fetus if used during pregnancy. Animal studies have revealed adverse reactions on fetal development when pregnant animals have been treated with Esloric Tablet 100 mg. Therefore, your doctor may not recommend the use of Esloric Tablet 100 mg during pregnancy. Women who are pregnant or breastfeeding must consult with their doctor before taking Esloric Tablet 100 mg.
Esloric Tablet 100 mg is classified as pregnancy category L3, meaning that it is unlikely to cause harm to nursing infants when used during lactation. However, women who are pregnant or breastfeeding must consult with their doctor before taking Esloric Tablet 100 mg.
An overdose of Esloric Tablet 100 mg can cause symptoms such as drowsiness, confusion, dizziness, nausea, seizures, and severe abdominal or back pain. If you or someone you know has taken an overdose of Esloric Tablet 100 mg, seek immediate medical attention. Do not attempt to induce vomiting or take any other action until a medical professional advises you to do so.
Esloric Tablet 100 mg should not be used in patients who are allergic to it or any of its components. Additionally, Esloric Tablet 100 mg should not be used by individuals who have a history of liver or kidney disease, diabetes, or hypothyroidism.
Esloric Tablet 100 mg should be taken orally, usually once daily or as directed by your doctor. Esloric Tablet 100 mg tablets should not be crushed, broken, or chewed before swallowing.
Esloric Tablet 100 mg should be stored at room temperature in a dark and dry place. The tablets should not be exposed to light, moisture, or extreme temperatures.
The volume of distribution of Esloric Tablet 100 mg is estimated to be 0.5-1 L/kg.
The plasma half-life of Esloric Tablet 100 mg is estimated to be 1.9-4.5 hours.
The renal clearance of Esloric Tablet 100 mg is approximately 80 mL/min.
See in details version Esloric Tablet 100 mg also Esloric Tablet 100 mg in bangla